ライフサイエンスコーパス: uncertainty regarding

1 omatic/ subclinical, further contributing to uncertainty regarding a causal link between G. lamblia i

2 However, there has been significant uncertainty regarding a method to separately derive lung

3 el treatment, some patients may perceive the uncertainty regarding a reduction in treatment effective

4 Available data leave considerable uncertainty regarding actual risk of suicide attempt and

5 edness plans, however, there is considerable uncertainty regarding antiviral compliance rates.

6 out the role of deep groundwater, leading to uncertainty regarding Arctic water availability and chan

7 ith ACC tracking prediction errors to reduce uncertainty regarding available choices and striatum usi

8 plasma treatment exists suggesting clinical uncertainty regarding best practice, particularly as a p

9 pproximately half of the contrast arose from uncertainty regarding biological data, with the remainde

10 ns of future climate are highly sensitive to uncertainties regarding carbon (C) uptake and storage by

11 Currently existing uncertainties regarding carbon fluxes within terrestrial

12 across all end points indicated substantial uncertainty regarding comparative effectiveness.

13 Uncertainty regarding complication management could cont

14 (2) the risk of donor harm posed by NRP, (3) uncertainties regarding consent requirements for NRP, (4

15 e standard, should be considered if there is uncertainty regarding contributing causes of liver injur

16 Previous uncertainties regarding coreceptor usage by PR T-cell-tr

17 findings suggest the continued existence of uncertainty regarding coverage for NGS, despite the NCD.

18 The secondary outcome was participants' uncertainty regarding decision making (score range, 3 to

19 y pose significant clinical challenges, with uncertainties regarding diagnostic and therapeutic appro

20 of this state from MDS, and current areas of uncertainty regarding diagnostic criteria for myeloid ma

21 Additionally, we assessed structural uncertainty regarding direct, body mass index (BMI)-inde

22 s in donor lung utilization due, in part, to uncertainty regarding donor quality.

23 se Loess Plateau (CLP) is debated because of uncertainties regarding dust provenance.

24 However, because of uncertainties regarding effect sizes, confidence interva

25 chanisms, a lack of available expertise, and uncertainty regarding effective therapeutics.

26 executing the movement, which contributed to uncertainty regarding end-position location.

27 the molecular characteristics, there remains uncertainty regarding epidemiologic trends and environme

28 Given continued uncertainty regarding functional roles of DH-associated

29 and 36 months of age, there is considerable uncertainty regarding future development.

30 MOs were more likely to report uncertainty regarding general preventive care responsibi

31 o adjust for all sources of confounding, and uncertainty regarding generalizability to countries outs

32 Uncertainties regarding how hospice affects health care

33 Nonetheless there is concern and uncertainty regarding how and at what spatial scales ant

34 There is uncertainty regarding how to interpret discordance betwe

35 ation thrombotic microangiopathy illustrates uncertainties regarding incidence, risk factors, diagnos

36 and ethnic groups, and there continues to be uncertainty regarding increasing prevalence of myopia.

37 To address uncertainties regarding indications and efficacy, the Am

38 d restricted) were inversely associated with uncertainties regarding inputs to economic models inform

39 Uncertainties regarding instrument specifications and ca

40 There is considerable uncertainty regarding intra-abdominal drainage after pan

41 applied to understand nitrogen (N) dynamics, uncertainties regarding intraspecific and temporal varia

42 ivo should make it possible to resolve these uncertainties regarding its functions and regulation in

43 , the pentacene triplet is non-emissive, and uncertainty regarding its energy has hindered device des

44 de disability but there remains considerable uncertainty regarding its neural and behavioural associa

45 r due to a lack of objective diagnostics and uncertainty regarding its perceptual outcomes.

46 ced, adoption of ALA has been limited due to uncertainty regarding its sensitivity to minor changes,

47 uation in women with DCIS undergoing BCS and uncertainty regarding its use with mastectomy, SLNB or A

48 trengthen and expand west, but there remains uncertainty regarding its variability and linkages to na

49 s while macroscopic treatments involve major uncertainties regarding key features.

50 their relative importance is complicated by uncertainty regarding kill mechanisms and the relative t

51 This patchwork of regulation and enforcement uncertainty regarding LDTs and public concerns about acc

52 First, we show that perceptual uncertainty regarding letter position is not tied to Eur

53 rs of infected patients across the globe and uncertainty regarding management of the complications th

54 ineligible for clinical trials and enormous uncertainty regarding management reigns, often to the po

55 ng pregnancy remain controversial because of uncertainties regarding maternal fat deposition and redu

56 turely born infants is inevitable because of uncertainty regarding media transmissivity, but this dis

57 Policy approaches to further reduce uncertainty regarding NGS coverage and raise awareness o

58 ing to an under-appreciation of the inherent uncertainties regarding nomogram use.

59 There is uncertainty regarding optimal diagnostic criteria, defin

60 omparing targeted and immunotherapies leaves uncertainty regarding optimal first-line treatment.

61 ontroversial due to geographic disparity and uncertainty regarding optimal prioritization of candidat

62 e in childhood CHD are lacking, resulting in uncertainty regarding optimal strategies for preventing

63 volved over recent decades but there remains uncertainty regarding optimal treatment selection and se

64 ition including a discussion of the level of uncertainty (regarding outcome) inherent in each individ

65 ighting the need to investigate the critical uncertainties regarding pathophysiology, risk factors an

66 e patients self-identified as black, raising uncertainty regarding performance in blacks with HF.

67 ies can be difficult to determine because of uncertainty regarding population genetic variation and a

68 However, there is uncertainty regarding potential differential effects of

69 These findings are subject to substantial uncertainty regarding private-sector treatment patterns,

70 for nurses when there are varying degrees of uncertainty regarding prognosis.

71 opularity in this setting; however, there is uncertainty regarding prostate sampling, infection rates

72 licting biochemical experiments have created uncertainty regarding Rab11 activation.

73 ction and Affordable Care Act, together with uncertainty regarding reauthorization of the Children's

74 re during training, unclear career path, and uncertainty regarding reimbursement.

75 on (AF) remains controversial because of the uncertainty regarding risk-benefit assessments.

76 imary TB time-series data in FSU prisons and uncertainties regarding screening test characteristics.

77 tions to climate change is hindered by major uncertainties regarding seagrass extent and distribution

78 ated by heterogeneity of the rock record and uncertainties regarding selection and preservation bias.

79 amine current knowledge and areas of ongoing uncertainty regarding senescence in the human kidney and

80 red with those without ARF mainly due to the uncertainty regarding short-term and long-term outcomes.

81 ensive synonymy within the genus, leading to uncertainty regarding species recognition.

82 these phenomena are the result of excessive uncertainty regarding state transitions (transition unce

83 However, globally, these effects reduce uncertainty regarding stimulus location and actually inc

84 The results clarify uncertainties regarding structure/function relationships

85 These technologies face challenges, such as uncertainty regarding target identity, non-specific bind

86 axonomic identification of these fossils and uncertainties regarding the age of the deposit, therefor

87 Uncertainties regarding the analytical performance and i

88 Some uncertainties regarding the benefit of beta-blockers for

89 decompensated cirrhosis and the accompanying uncertainties regarding the best precirrhotic trial endp

90 blocker protection approach, by eliminating uncertainties regarding the blocked conformations of the

91 luding in particular the substantial current uncertainties regarding the clinical implications of aor

92 Model structure uncertainties regarding the concentration-response model

93 cyclooctasulfur (S(8)), clarifying enduring uncertainties regarding the content of microbial sulfur

94 We account for uncertainties regarding the damage curve, climate sensit

95 mes are artificial designations that reflect uncertainties regarding the diagnostic limits of classic

96 ble and macroscopic treatments involve major uncertainties regarding the dielectric constant used and

97 Irreducible uncertainties regarding the dose-response curve prevent

98 Uncertainties regarding the duration of post-vaccination

99 well below acute toxic levels, but there are uncertainties regarding the effects of chronic exposures

100 However, there are large uncertainties regarding the effects of climate warming o

101 al attachment are well documented, there are uncertainties regarding the expression and function of B

102 epsy presents a significant challenge due to uncertainties regarding the extent of resection necessar

103 However, because of uncertainties regarding the interpretation of the result

104 However, fundamental uncertainties regarding the materials, features, ages an

105 Uncertainties regarding the most appropriate definition

106 Although uncertainties regarding the optimal use of liquid biopsy

107 However, such a role is obscured by uncertainties regarding the representation of dynamic fo

108 dy of knowledge on STO, there are still many uncertainties regarding the role of defects in the prope

109 Uncertainties regarding the specificity of pharmacologic

110 Despite uncertainties regarding the starting date of the release

111 This paper brings together key scientific uncertainties regarding the use of serological tests to

112 prophylaxis (PrEP) are scarce and there are uncertainties regarding the value of routine HIV-1 RNA t

113 ate that this uncertainty is low relative to uncertainties regarding the value of statistical life an

114 However, uncertainties regarding the volumes of milk ingested by

115 f care in the private sector and substantial uncertainty regarding the 1-y period prevalence of TB in

116 art disease remains challenging owing to the uncertainty regarding the ability of relatively immature

117 ty index score or Hestia rule), but there is uncertainty regarding the applicability in underrepresen

118 A drawback of AR however is related to uncertainty regarding the AR user's focus of attention i

119 There is clinical uncertainty regarding the benefits and harms of prescrib

120 This results in uncertainty regarding the best antithrombotic strategies

121 There is uncertainty regarding the BG's influence on timing proce

122 any laboratories, there is still significant uncertainty regarding the biochemical attributes of clas

123 gical effects of anemia in humans has caused uncertainty regarding the blood hemoglobin (Hb) concentr

124 itives and low levels of viremia have led to uncertainty regarding the burden of active infection in

125 cell viability and helps explain the current uncertainty regarding the cellular role of Bok.

126 There is uncertainty regarding the clinical effects of discontinu

127 ries based on CYP2C19 genotype, but there is uncertainty regarding the clinical risk imparted by spec

128 with radical nephrectomy, have generated new uncertainty regarding the comparative effectiveness of t

129 ficacy of modern lithotripters, have created uncertainty regarding the comparative effectiveness of t

130 Architectural uncertainty regarding the cytoplasmic C-ring, or 'switch

131 was not possible until recently, because of uncertainty regarding the densities and intrinsic pKa va

132 are difficult to interpret because there is uncertainty regarding the diagnosis of TTP-HUS and becau

133 Because there is often uncertainty regarding the dilated aortic root, this revi

134 lth is nearly universal, there is persistent uncertainty regarding the dimensions of SES that effect

135 haracterised by a scarcity of data and great uncertainty regarding the disease burden and distributio

136 placed femoral neck fractures, there remains uncertainty regarding the effect of a total hip arthropl

137 There is uncertainty regarding the effectiveness and occurrence o

138 However, uncertainty regarding the effectiveness of these approac

139 However, there is uncertainty regarding the efficacy and safety of these p

140 There is uncertainty regarding the efficacy of increasing n-3 lon

141 However, there remains some uncertainty regarding the efficacy of these catheters be

142 Despite uncertainty regarding the efficacy, axillary evaluation

143 Given uncertainty regarding the estimated effect size, this ap

144 However, there has been historic uncertainty regarding the evolutionary and conservation

145 Given uncertainty regarding the exact amount of SSBs consumed

146 must be made in the presence of substantial uncertainty regarding the feasibility and costs of elimi

147 red systems, yet there is still considerable uncertainty regarding the formation and potential stabil

148 ous acid (HOCl), there is still considerable uncertainty regarding the formation mechanisms and ident

149 d disease outcomes but there is considerable uncertainty regarding the frequency of poor prognosis es

150 Limited surveillance has led to uncertainty regarding the geographic ranges of these vec

151 An appropriate uncertainty regarding the human life span undermines any

152 There is uncertainty regarding the ideal extent of lymphadenectom

153 However, uncertainty regarding the ideal neural targets remains,

154 R in vitro is Mn2+-dependent, have generated uncertainty regarding the identities of the ligand(s) an

155 There is uncertainty regarding the impact of statins on the risk

156 e clinical and micromachining setting is the uncertainty regarding the impact on the composition of m

157 be used to predict vaccine effectiveness and uncertainty regarding the impact that infection-induced

158 Workshop participants also pointed to uncertainty regarding the importance of maintaining norm

159 However, there is considerable uncertainty regarding the incidence, duration, and sever

160 The methodology is complicated by uncertainty regarding the integrity of sEVs after nebuli

161 esidency at the expense of nuclear medicine; uncertainty regarding the international recognition of n

162 s and elsewhere is challenged by substantial uncertainty regarding the location and timing of fire ev

163 g nomadic foragers in variable environments: uncertainty regarding the location of food sources and v

164 mbotic disorders is impeded by long-standing uncertainty regarding the magnitude of venous and arteri

165 Thus, we explore the uncertainty regarding the main assumptions and different

166 However, there is uncertainty regarding the mechanism(s) of complex format

167 he pathogenesis of acute pancreatitis is the uncertainty regarding the mechanisms responsible for the

168 However, due to uncertainty regarding the mechanisms that coordinate the

169 Uncertainty regarding the mechanistic relationship betwe

170 In addition, there has been uncertainty regarding the methionine start site of ATP8A

171 osocomial malaria transmissions, despite the uncertainty regarding the modes of contamination.

172 , but their development has been hindered by uncertainty regarding the molecular mechanism of partial

173 Uncertainty regarding the most appropriate modeling meth

174 has indeed translated into a high degree of uncertainty regarding the most appropriate treatment of

175 wing to conflicting data, there remains some uncertainty regarding the most beneficial perioperative

176 of those with PVCs is variable, with ongoing uncertainty regarding the most informative predictors of

177 Rationale: Uncertainty regarding the natural history of coronavirus

178 ing has paradoxically introduced substantial uncertainty regarding the nature and meaning of neuroinf

179 However, there is uncertainty regarding the nature of CeM control over con

180 n is advantageous when there is considerable uncertainty regarding the nest location.

181 nd respiration which results in considerable uncertainty regarding the net carbon dioxide (CO(2)) bal

182 e based on low-quality evidence and there is uncertainty regarding the net clinical benefit of AA.

183 eir genetic basis remains unknown because of uncertainty regarding the number and identity of ovarian

184 depending on the shape of the utility curve, uncertainty regarding the number of offspring may or may

185 To introduce uncertainty regarding the object's properties, the pendu

186 Given the uncertainty regarding the optimal approach for airway ma

187 Given the uncertainty regarding the optimal approach to laryngosco

188 There is substantial uncertainty regarding the optimal surgical treatment for

189 prior injection interval-introduces further uncertainty regarding the optimal treatment strategy.

190 However, there is uncertainty regarding the optimum regimen and dosage.

191 studies of phase slips have been limited by uncertainty regarding the order parameter's free-energy

192 membranes and cellular organelles has led to uncertainty regarding the origin of the viral membrane.

193 f WGDs within a major plant clade has led to uncertainty regarding the potential association of WGDs

194 chanism by which this complex forms has been uncertainty regarding the precise metallocluster composi

195 There is also uncertainty regarding the predictive power of exercise c

196 nt is to gather data that allow us to reduce uncertainty regarding the probabilities of events.

197 tabolism has been offset by the considerable uncertainty regarding the proteins that store and distri

198 water infrastructure is understood to reduce uncertainty regarding the provision of individually valu

199 he diagnosis of TTP-HUS and because there is uncertainty regarding the relation of drug exposure to t

200 There is uncertainty regarding the relative importance of SLE dis

201 Furthermore, there remains uncertainty regarding the relative importance of small a

202 ral diatoms, we describe numerous sources of uncertainty regarding the reliability of these records.

203 ed by the development of mixed chimerism and uncertainty regarding the risk of HLH recurrence.

204 survivors of childhood cancer, but there is uncertainty regarding the risks of bone tissue radiation

205 This leads to uncertainty regarding the role of enemy release in biolo

206 different imaging modalities, there is still uncertainty regarding the role of these tests in clinica

207 Following injury, there is uncertainty regarding the role that accumulating CCR2(+)

208 lear benefit on HF-related outcomes and even uncertainty regarding the safety in those with HF with r

209 ase 2019 (COVID-19) resulted in an increased uncertainty regarding the safety of allergen immunothera

210 One barrier to booster vaccination is uncertainty regarding the safety of booster doses among

211 e clinician's despair is only exacerbated by uncertainty regarding the significance of laboratory ind

212 Considerable uncertainty regarding the sources of meltwater limits un

213 ay of branch formation is ambiguous owing to uncertainty regarding the stoichiometry and location of

214 g the number of DCD donations resides in the uncertainty regarding the timing of cardiac death after

215 ted the struggle of families to navigate the uncertainty regarding the timing of death during the don

216 This leads to uncertainty regarding the treatment of older patients wi

217 s are considerable, and there is substantial uncertainty regarding the true disease burden.

218 xotic superconductivity have been impeded by uncertainty regarding the underlying electronic structur

219 f the available literature, there remains an uncertainty regarding the underlying hypothesis.

220 in agriculture remains controversial due to uncertainty regarding the unintended release of genetic

221 However, there is uncertainty regarding the value of baseline ultrasonogra

222 mmunity, given the lack of data and inherent uncertainties regarding their development.

223 development of the eukaryotic lineage, major uncertainties regarding their origins and evolution rema

224 However, there is uncertainty regarding their cardiac specificity and util

225 dition with multiple systemic treatments and uncertainty regarding their comparative impact on AD out

226 is discussed, but there remains considerable uncertainty regarding their optimum management and progn

227 side effect profiles and coping with greater uncertainty regarding their prognosis.

228 However, there is still uncertainty regarding their prognostic implications.

229 Remaining uncertainty regarding their symptoms and diagnosis may c

230 ndeterminate pathobiology of MGZL has led to uncertainty regarding therapeutic strategy, and its clin

231 PLR effectiveness increased with greater uncertainty regarding therapy effectiveness or in sicker

232 and decrease interinstitutional mistakes and uncertainties regarding these neoplasms.

233 Because of uncertainty regarding these values and related assumptio

234 There remain many uncertainties regarding this pathway.

235 s paper addresses clinical controversies and uncertainties regarding thoracic aortic aneurysm and its

236 Given existing uncertainty regarding trade-offs between the quantity an

237 There is ongoing uncertainty regarding transmission chains and the respec

238 gnostic test characteristics for some tests, uncertainty regarding true positives and causation of il

239 There is therapeutic uncertainty regarding use of combination or single-agent

240 Concerns centered on uncertainty regarding vaccine safety, questions about ef

241 Uncertainty regarding viral chemokine function is mirror

242 on of cases associated with the outbreak and uncertainty regarding viral load across both the course

243 with frustration and anxiety, in part due to uncertainty regarding when anaphylaxis might occur.

244 There is uncertainty regarding when and which groups of neurons f

245 While there is still much uncertainty regarding when, how and the circumstances un

246 They noted evolving concerns and uncertainties regarding whether subclinical (mild, asymp

247 At the present time, there is uncertainty regarding whether endocrine intervention, pa

248 troversial and variably regulated because of uncertainty regarding whether financial incentives serve

249 d after treatment interruption, but there is uncertainty regarding whether modern antiretroviral ther

250 In particular, there has been uncertainty regarding whether ospC is controlled directl

251 In many countries, there is significant uncertainty regarding whether PMIs are lawful or, if the

252 There has been uncertainty regarding whether single or bilateral lung t

253 t for laboratories offering the service, and uncertainty regarding whether target populations with th

254 There is uncertainty regarding which brand-name prescription drug

255 om the display is needed to resolve semantic uncertainty regarding which object is present.

256 However, there is still uncertainty regarding which proteases are critical for H

257 t can activate HA is growing, there is still uncertainty regarding which secreted proteases are able